Bio-Rad Laboratories, Inc. (BIO-B) is expected to report earnings on Thursday, October 22, 2026, after the close. Estimated release time 16:17 ET. Consensus EPS estimate is $2.19.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-04-30 | FY2026 Q1 | $2.01 | $1.89 | -6.0% | $592.10M |
| 2025-10-29 | FY2025 Q3 | $1.89 | $2.26 | +19.6% | $653.00M |
| 2025-05-01 | FY2025 Q1 | $1.82 | $2.29 | +25.8% | $585.40M |
| 2025-02-14 | FY2024 Q4 | $2.86 | $2.90 | +1.4% | $667.48M |
| 2024-08-02 | FY2024 Q2 | $2.05 | $3.11 | +51.7% | $638.48M |
| 2023-10-27 | FY2023 Q3 | $2.76 | $3.65 | +32.2% | $632.12M |
| 2023-08-04 | FY2023 Q2 | $2.64 | $3.00 | +13.6% | $681.11M |
| 2023-05-05 | FY2023 Q1 | $3.63 | $2.33 | -35.8% | $676.84M |
BIO-B has beaten consensus EPS in 6 of its last 8 reported quarters.
See BIO-B on the live calendar →